Sign Out
Hypersensitivity to oxaliplatin, other platinum compounds (e.g., cisplatin, carboplatin) or any component in the product.
Patients with peripheral sensory neuropathy with functional impairment prior to first course.
Patients with severely impaired renal function (Clcr <30 mL/min).
Patients with myelosuppression prior to starting first course, with baseline neutrophils <2 x 109/L and/or platelet count of <100x 109/L.
Patients who are pregnant or breastfeeding.
Continue with Google